Regenerative medicine's genuine promise, combined with patients' understandable hope, has made this field particularly vulnerable to overstated marketing claims. Here's a direct guide to spotting them.
Language red flags
- "Cure" — no responsible provider uses this word for the conditions typically treated in this field, given the current evidence base
- "Guaranteed results" — biological treatments cannot ethically be guaranteed
- "Miracle" or "breakthrough" — emotionally compelling language that substitutes for, rather than accompanies, actual evidence
- Vague claims about treating a long, unrelated list of conditions — a legitimate treatment has a scoped, evidence-supported set of applications, not an ever-expanding list
A responsible provider's marketing sounds more measured than you might expect — because the honest evidence, while genuinely promising in specific areas, doesn't support sweeping claims. Measured language is a positive signal, not a lack of confidence.
Practice red flags
- No mention of FDA/INVIMA regulatory status when asked directly (see our regulatory status guide)
- Fabricated or unverifiable-sounding statistics ("95% success rate" with no source or methodology)
- Pressure to book immediately, especially framed around urgency or scarcity
- Reluctance to discuss the specific evidence level for your particular condition
What legitimate marketing actually sounds like
Something closer to: "For your specific condition, current evidence shows [specific, honest description of outcomes] in [specific patient population]. This is not FDA/INVIMA-approved for this specific use, but is offered under [specific regulatory framework]." Less exciting than "miracle cure" — and far more trustworthy.
What to do if you spot these red flags
Seek a second opinion from a provider willing to discuss evidence and regulatory status directly and specifically — see our full vetting checklist for a complete framework.
Ready to talk to someone?
Message us on WhatsApp for a free, no-obligation consultation.